Dr. Lal PathLabs reported a revenue of Rs 603 Cr for Q4 FY 2024-25, reflecting a 10.5% increase from the previous year, with EBITDA up 16.9% and PAT rising 81.4%; they announced a fourth interim dividend of Rs. 6 per share.
AI Assistant
Dr Lal Pathlabs Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.